Phospho-Drp1 (Ser637) (Cell Signaling Technology, #6319), Total GSK3 (Cell Signaling Technology, #12456), Total Drp1 (Cell Signaling Technology, #8570), and GAPDH (Cell Signaling Technology, #2118)
Research groups have published on growth-hormone-secretagogue stacks such as GHRP-6 paired with a GHRH analog combining fragments for different aspects of the GH axis, on cognitive-research stacks combining nootropic-class peptides with neurotrophic compounds, and on anti-inflammatory stacks combining KPV with other immunomodulatory fragments which is exactly why the KLOW blend was designed with KPV included
Why I used it: For a triceps rupture, targeted healing is non-negotiable
Less common but serious adverse effects seen in the clinical trials are pancreatitis (inflammation of the pancreas), gallbladder disease (such as gallstones), and worsening of diabetic retinopathy